Skip to content
Review

AI and Deep Learning in Cardiovascular Imaging: From Risk Stratification to Precision Phenotyping.

Oct 2026 · Arteriosclerosis, Thrombosis and Vascular Biology · 0 citations · 80 references
Medicine

TL;DR

Artificial intelligence is expanding the role of cardiovascular imaging from visual interpretation toward integrated assessment for risk stratification and precision phenotyping, though further work is needed to confirm generalizability and real-world performance before these tools can guide individual patient management.

Abstract

Cardiovascular imaging plays a central role in the diagnosis, risk stratification, and management of cardiovascular disease, yet the complexity and volume of imaging data increasingly exceed the capacity of conventional interpretation. Artificial intelligence (AI) and deep learning offer new tools to extract quantitative, prognostic, and phenotypic information from routine cardiovascular images. This review summarizes the fundamentals of AI and deep learning, including model architectures, training strategies, and their relevance to cardiovascular imaging, followed by a focused discussion of current applications across chest radiography, chest computed tomography, computed tomography angiography/cardiac computed tomography, cardiac magnetic resonance imaging, echocardiography, and nuclear cardiology imaging. Studies were selected with emphasis on original investigations, large cohort analyses, and external validation studies reflecting current applications of AI in cardiovascular risk stratification and precision phenotyping. Across these modalities, AI applications in automated image processing and analysis have become relatively mature. Multiple multicenter and real-world studies have validated their value in improving efficiency and supporting cardiovascular management. Approaches that move beyond conventional human-defined imaging metrics to infer cardiovascular risk and disease phenotype remain at an earlier stage, requiring further standardization, validation, and clinical evaluation. AI is expanding the role of cardiovascular imaging from visual interpretation toward integrated assessment for risk stratification and precision phenotyping, though further work is needed to confirm generalizability and real-world performance before these tools can guide individual patient management.

View source

Similar papers

Current Medical Imaging

Mei-Lan Zhang, Jing Li, Yan Wang et al. · 0 citations

Current Medical Imaging

The PRAD-Hybrid CNN (Prostate Adenocarcinoma Hybrid Convolutional Neural Network, PRADHC) model, a novel amalgamation of EfficientNet and Residual Blocks, which was developed and validated, improved the diagnostic accuracy inherent to the original EfficientNet by strategically increasing the number of Convolutional Neu...

Ke-Xin Jiang, Wen-Yan Liu, Yang Xu et al. · 3 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.